Daily non-political popular news in brief.

Study first: Over-expression of Cox-2 can predict prostate cancer outcome

Researchers say an over-expression of COX-2 in men with prostate cancer is associated with an increase in PSA after radiation treatment and the spread of the cancer outside of the prostate. That is the result of the first study linking COX-2 with prostate cancer radiation treatment outcomes.

Read more »

Keywords: study, over-expression, cox-2, predict, prostate, cancer, outcome, over, expression, cox

« Previous | Next »

Similar news on "Study first: Over-expression of Cox-2 can predict prostate cancer outcome":

1. Annals of Internal Medicine tip sheet for Feb. 5, 2008, issue
   02-04-2008 · EurekAlert!
   In the Feb. 5, 2008 issue of the Annals of Internal Medicine are "No Clear Winner in Comparative Review of Effectiveness and Harms of Treatments for Localized Prostate Cancer"; "Gene Expression Tests for Breast Cancer Are Promising But Limited"; "New Study Refines Thinking on Best Time to Begin HIV Treatment"; and "Expert Group: Do Not Screen Pregnant Women for Bacterial Vaginosis."
   Similar news · Read more »
   
2. MR imaging helps predict recurrence in prostate cancer patients
   05-04-2007 · EurekAlert!
   MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return, according to a recent study conducted by radiologists at the University of California-San Francisco.
   Similar news · Read more »
   
3. Outcome of prostate cancer surgery depends on the experience of the surgeon
   07-24-2007 · EurekAlert!
   According to a new study published online today in the Journal of the National Cancer Institute, prostate cancer patients treated by highly experienced surgeons are much more likely to be cancer-free five years after surgery than patients treated by surgeons with less experience.
   Similar news · Read more »
   
4. T-beta-RIII joins the fight against breast cancer
   12-07-2006 · EurekAlert!
   Although the soluble factor TGF-beta suppresses tumor cell growth in early breast cancer, high TGF-beta levels later in disease are associated with a poor outcome. A new study using human breast cancer samples and mice, indicates that changes in expression of one TGF-beta receptor component, T-beta-RIII, might explain the distinct effects of TGF-beta at the different stages of breast cancer and that analysis of T-beta-RIII levels might help clinicians decide how aggressively to treat patients.
   Similar news · Read more »
   
5. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
   06-04-2007 · EurekAlert!
   The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial. The findings, if backed by larger studies, could have important implications for designing personalized treatments for this very dangerous type of prostate cancer, says a Jefferson Medical College researcher and study first author.
   Similar news · Read more »
   
6. Genetic marker linked to aggressive prostate cancer
   05-20-2007 · EurekAlert!
   Northwestern University researchers have discovered that a recently identified genetic marker for prostate cancer is linked to a highly aggressive form of the disease. These findings ultimately will aid the development of a simple blood test to predict who is susceptible to this aggressive cancer. Knowing which patients carry this genetic marker also will guide doctors in how they treat the cancer. The study showed a strong hereditary component to this aggressive cancer.
   Similar news · Read more »
   
7. PSA testing can predict advanced prostate cancer
   02-14-2008 · EurekAlert!
   A single prostate specific antigen test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan-Kettering Cancer Center in New York and Lund University in Sweden.
   Similar news · Read more »
   
8. High pretreatment PSA velocity predicts worse outcome
   05-25-2007 · EurekAlert!
   The most significant single predictor of aggressive prostate cancer is an elevated rate of increase in prostate specific antigen (PSA) levels, according to a new study.
   Similar news · Read more »
   
9. PSA is poor predictor of lethal prostate cancer
   04-03-2007 · EurekAlert!
   The amount of prostate-specific antigen (PSA) in a man's bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease does not adequately predict lethal prostate cancer, according to a study in the April 4 Journal of the National Cancer Institute.
   Similar news · Read more »
   
10. Study identifies multiple genetic risk factors for prostate cancer
    04-01-2007 · EurekAlert!
    A study led by researchers at the Keck School of Medicine of the University of Southern California and Harvard Medical School has identified seven genetic risk factors that predict risk for prostate cancer. According to the study's findings, these risk factors are clustered in a single region of the human genome on chromosome 8 and powerfully predict a man's probability of developing prostate cancer.
    Similar news · Read more »